Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Gynecol Endocrinol ; 35(2): 170-173, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30324831

RESUMEN

Circulating anti-müllerian hormone (AMH) and antral follicle count (AFC) are the best predictors of IVF outcomes. However, in extreme low AMH range especially for young patients, AMH prediction power loose its specificity to give real idea of pregnancy chance with IVF treatments and good prognosis of an extremely reduced ovarian reserve and expected poor response. Indeed, this retrospective study was conducted to evaluate IVF outcomes in patients following IVF-ICSI program with extremely low AMH levels (≤0.4 ng/ml; n = 390) compared to those presenting normal AMH range (1.3-2.6 ng/ml; n = 352) considered as control group. As expected, number of oocytes retrieved per patient, and embryological outcomes were significantly lower in the extremely low AMH levels group compared to control. Moreover, it was same trend concerning clinical outcomes but we have to note that even in extreme low AMH, patients could reach ineligible satisfying clinical pregnancy rate compared to control (17% vs 41%). For patients younger than 35 years, clinical pregnancy rate improved to 27%. Women with extreme low AMH values and especially younger ones, still have reasonable chances of achieving pregnancy, highlighting the default view of this category generally excluded from IVF program.


Asunto(s)
Hormona Antimülleriana/sangre , Fertilización In Vitro , Índice de Embarazo , Adulto , Factores de Edad , Estudios de Casos y Controles , Femenino , Humanos , Recuperación del Oocito , Folículo Ovárico , Reserva Ovárica , Inducción de la Ovulación , Embarazo , Pronóstico , Estudios Retrospectivos , Inyecciones de Esperma Intracitoplasmáticas , Resultado del Tratamiento
2.
Fertil Steril ; 110(4): 710-719, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-30196968

RESUMEN

OBJECTIVE: To study the effectiveness of a new in vitro maturation (IVM) approach based on heterologous follicular fluid (HFF) and supernatant of cumulus-granulosa cells (CGCs) mimicking the intact follicular microenvironment to rescue immature denuded oocytes (IDOs) of patients with polycystic ovary syndrome (PCOS) whose IVM or IVF outcomes remain poor. DESIGN: Randomized controlled trial. SETTING: University-affiliated private center. PATIENT(S): One hundred fifty-nine IDOs were obtained from 47 patients with PCOS. First, a simple IVM system (S-IVM; 40 IDOs; control group) was compared with different protocols based on the addition of autologous follicular fluid (AFF-IVM; 44 IDOs), HFF (HFF-IVM; 42 IDO), or HFF with CGC isolated from seven women without PCOS and presenting 100% in vivo oocyte maturation (HFF/CGC-IVM; 33 IDOs). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): IVM outcomes were compared among the four groups (S-IVM, AFF-IVM, HFF-IVM, HFF/CGC-IVM); then the vitro and in vivo maturation results (from controlled ovarian stimulation of PCOS patients) were compared for each group. RESULT(S): The HFF/CGC-IVM method gave the best yield of developed blastocysts per IDO compared with S-IVM, AFF-IVM, and HFF-IVM (27% vs. 2%, 2%, and 12%, respectively). The IVM rate with the HFF/CGC-IVM method was even higher than that compared with the in vivo maturation rate (79% vs. 42%), with significant improvement in the cleavage rate (71% vs. 61%). CONCLUSION(S): This adapted IVM system could be used to reach an acceptable result in meiotic competence and competent metaphase II oocytes capable of developing into intact embryos after fertilization and before transfer.


Asunto(s)
Células del Cúmulo/fisiología , Líquido Folicular/fisiología , Técnicas de Maduración In Vitro de los Oocitos/métodos , Síndrome del Ovario Poliquístico/terapia , Adulto , Aumento de la Célula , Células Cultivadas , Femenino , Humanos , Técnicas de Maduración In Vitro de los Oocitos/tendencias , Infertilidad Femenina/diagnóstico , Infertilidad Femenina/terapia , Síndrome del Ovario Poliquístico/diagnóstico
3.
Mol Reprod Dev ; 85(3): 271-280, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29392876

RESUMEN

This study assessed sperm quality declining on relation to paternal age and its impact on in vitro fertilization (IVF) outcomes in order to estimate the APA (Advanced Paternal Age) cutoff. For this, 83 couples undergoing IVF treatment for male factor infertility were enrolled. The women age was ≤39 years, whereas the men were divided in two groups: APA (n = 41; age ≥ 40 years) and young (Y) (n = 42; age < 40 years). Conventional semen parameters (volume, concentration, motility, vitality, and morphology) were analyzed in the collected sperm samples. Furthermore, sperm genome decays (SGD) was assessed by TUNEL assay (DNA fragmentation), aniline blue staining (chromatin decondensation), and fluorescent in situ hybridization (aneuploidy). No significant difference was found concerning the conventional semen parameters between APA and Y groups. Conversely, SGD analysis showed increased DNA fragmentation; chromatin decondensation and sperm aneuploidy rates in the APA group (respectively, 41%, 43%, and 14% vs. 25%, 23%, and 4% in Y group). IVF outcomes also were affected by paternal age as indicated by the rates of cancelled embryo transfers, clinical pregnancy and miscarriage in the two groups APA and Y (29%, 17%, and 60% vs. 10%, 32%, and 42%). Finally, statistical analysis of the results suggests that the age of 40 should be considered as the APA cutoff during ART attempts.


Asunto(s)
Genoma , Hibridación Fluorescente in Situ , Infertilidad Masculina/genética , Edad Paterna , Espermatozoides/metabolismo , Adulto , Factores de Edad , Fragmentación del ADN , Femenino , Fertilización In Vitro , Humanos , Masculino , Persona de Mediana Edad , Embarazo , Resultado del Embarazo , Índice de Embarazo , Análisis de Semen
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA